Compare Abeona Therapeutics Inc (ABEO) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Citius Pharmaceuticals Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Abeona Therapeutics Inc is far larger — about 21× Citius Pharmaceuticals Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | CTXR | |
|---|---|---|
Market Cap | $421.19M | $20.01M |
Sector | Health | Health |
52-Week High | $7.45 | $1.82 |
52-Week Low | $4.17 | $0.48 |
Enterprise Value | $276.10M | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
